Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionP-type calcium transporter activity

ATP2A1 ATP2A2 ATP2A3

2.12e-0611483GO:0005388
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC5A5 SLC16A9 SLC17A3 ATP2A1 ATP2A2 ATP2A3 SLC25A23 SLC5A2

1.63e-05477488GO:0022804
GeneOntologyMolecularFunctioncalcium-dependent ATPase activity

ATP2A1 ATP2A3

3.38e-054482GO:0030899
GeneOntologyMolecularFunctionactive monoatomic ion transmembrane transporter activity

SLC5A5 SLC17A3 ATP2A1 ATP2A2 ATP2A3 SLC5A2

8.04e-05301486GO:0022853
GeneOntologyMolecularFunctionP-type transmembrane transporter activity

ATP2A1 ATP2A2 ATP2A3

8.80e-0536483GO:0140358
GeneOntologyMolecularFunctionP-type ion transporter activity

ATP2A1 ATP2A2 ATP2A3

8.80e-0536483GO:0015662
GeneOntologyMolecularFunctionmetal ion transmembrane transporter activity

SLC5A5 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC5A2

1.14e-04465487GO:0046873
GeneOntologyMolecularFunctioncarbohydrate derivative transmembrane transporter activity

ATP2A1 SLC25A23 SLC5A2

3.86e-0459483GO:1901505
GeneOntologyMolecularFunctioninorganic molecular entity transmembrane transporter activity

SLC5A5 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC25A23 SLC5A2

4.08e-04758488GO:0015318
GeneOntologyMolecularFunctionATPase-coupled monoatomic cation transmembrane transporter activity

ATP2A1 ATP2A2 ATP2A3

4.46e-0462483GO:0019829
GeneOntologyMolecularFunctionsymporter activity

SLC5A5 SLC16A9 SLC17A3 SLC5A2

4.60e-04150484GO:0015293
GeneOntologyMolecularFunctioncalcium ion transmembrane transporter activity

PKD1 ATP2A1 ATP2A2 ATP2A3

4.72e-04151484GO:0015085
GeneOntologyMolecularFunctionATP-dependent activity

DNHD1 SETX RTEL1 ATP10B ATP2A1 ATP2A2 ATP2A3

6.18e-04614487GO:0140657
GeneOntologyMolecularFunctioninorganic cation transmembrane transporter activity

SLC5A5 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC5A2

7.00e-04627487GO:0022890
GeneOntologyMolecularFunctionsecondary active transmembrane transporter activity

SLC5A5 SLC16A9 SLC17A3 SLC25A23 SLC5A2

7.03e-04296485GO:0015291
GeneOntologyMolecularFunctiontransporter activity

SLC5A5 SLC16A9 SLC17A3 PKD1 ATP10B ATP2A1 ATP2A2 ATP2A3 SLC25A23 SLC5A2

8.32e-0412894810GO:0005215
GeneOntologyMolecularFunctionsolute:sodium symporter activity

SLC5A5 SLC17A3 SLC5A2

9.75e-0481483GO:0015370
GeneOntologyMolecularFunctionmonoatomic cation transmembrane transporter activity

SLC5A5 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC5A2

9.80e-04664487GO:0008324
GeneOntologyMolecularFunctionphosphate transmembrane transporter activity

SLC17A3 SLC25A23

1.51e-0324482GO:0005315
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC5A5 SLC16A9 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC25A23 SLC5A2

1.77e-031180489GO:0022857
GeneOntologyMolecularFunctioncalcium ion binding

DUOX1 FBN2 PCDHA5 CUBN ATP2A1 ATP2A2 SLC25A23

1.96e-03749487GO:0005509
GeneOntologyMolecularFunctionATPase-coupled transmembrane transporter activity

ATP2A1 ATP2A2 ATP2A3

2.29e-03109483GO:0042626
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

SLC5A5 SLC17A3 PKD1 ATP2A1 ATP2A2 ATP2A3 SLC5A2

2.70e-03793487GO:0015075
GeneOntologyMolecularFunctionsolute:monoatomic cation symporter activity

SLC5A5 SLC17A3 SLC5A2

2.94e-03119483GO:0015294
GeneOntologyMolecularFunctionprotein homodimerization activity

SLC5A5 CD300H IRAK3 CST7 CUBN ATP2A1 LILRB5

3.15e-03815487GO:0042803
GeneOntologyMolecularFunctiontranscription regulator inhibitor activity

NFKBIA PKD1

3.38e-0336482GO:0140416
GeneOntologyMolecularFunctionATP hydrolysis activity

RTEL1 ATP10B ATP2A1 ATP2A2 ATP2A3

4.03e-03441485GO:0016887
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

GPR20 CD300H UNC5B MCHR2 PKD1 ADGRB3 OR2W1 IL18RAP LILRB5

4.45e-031353489GO:0004888
GeneOntologyMolecularFunction4 iron, 4 sulfur cluster binding

RTEL1 NFU1

5.71e-0347482GO:0051539
GeneOntologyBiologicalProcesscalcium ion transport from cytosol to endoplasmic reticulum

ATP2A2 ATP2A3

5.53e-062492GO:1903515
GeneOntologyBiologicalProcesspositive regulation of endoplasmic reticulum calcium ion concentration

ATP2A1 ATP2A2

1.66e-053492GO:0032470
GeneOntologyBiologicalProcessendoplasmic reticulum calcium ion homeostasis

ATP2A1 ATP2A2 ATP2A3

4.41e-0529493GO:0032469
GeneOntologyBiologicalProcessregulation of cardiac conduction

ATP2A1 ATP2A2 ATP2A3

4.41e-0529493GO:1903779
GeneOntologyBiologicalProcesscytosol to endoplasmic reticulum transport

ATP2A2 ATP2A3

5.50e-055492GO:0046967
GeneOntologyBiologicalProcesscalcium ion import into sarcoplasmic reticulum

ATP2A1 ATP2A2

1.15e-047492GO:1990036
GeneOntologyCellularComponentplatelet dense tubular network membrane

ATP2A1 ATP2A2 ATP2A3

1.07e-069503GO:0031095
GeneOntologyCellularComponentplatelet dense tubular network

ATP2A1 ATP2A2 ATP2A3

2.10e-0611503GO:0031094
GeneOntologyCellularComponentsarcoplasmic reticulum membrane

ATP2A1 ATP2A2 ATP2A3

1.70e-0445503GO:0033017
GeneOntologyCellularComponentbrush border membrane

SLC17A3 CUBN SLC5A2

1.03e-0383503GO:0031526
GeneOntologyCellularComponentsarcoplasmic reticulum

ATP2A1 ATP2A2 ATP2A3

1.22e-0388503GO:0016529
DomainHydrolase_3

ATP10B ATP2A1 ATP2A2 ATP2A3

7.31e-0910474PF08282
DomainP-type_ATPase_IIA

ATP2A1 ATP2A2 ATP2A3

1.49e-083473IPR005782
Domain-

ATP10B ATP2A1 ATP2A2 ATP2A3

1.20e-06324743.40.1110.10
Domain-

ATP10B ATP2A1 ATP2A2 ATP2A3

1.20e-06324742.70.150.10
DomainATPase_P-typ_cyto_domN

ATP10B ATP2A1 ATP2A2 ATP2A3

1.74e-0635474IPR023299
DomainP_typ_ATPase

ATP10B ATP2A1 ATP2A2 ATP2A3

1.95e-0636474IPR001757
DomainATPase_P-typ_P_site

ATP10B ATP2A1 ATP2A2 ATP2A3

1.95e-0636474IPR018303
DomainATPASE_E1_E2

ATP10B ATP2A1 ATP2A2 ATP2A3

1.95e-0636474PS00154
DomainATPase_P-typ_transduc_dom_A

ATP10B ATP2A1 ATP2A2 ATP2A3

2.19e-0637474IPR008250
DomainE1-E2_ATPase

ATP10B ATP2A1 ATP2A2 ATP2A3

2.19e-0637474PF00122
Domain-

ATP2A1 ATP2A2 ATP2A3

8.17e-06164731.20.1110.10
DomainATPase_P-typ_TM_dom

ATP2A1 ATP2A2 ATP2A3

8.17e-0616473IPR023298
DomainCUB

ADGRB3 CUBN CSMD1 CSMD2

9.42e-0653474PS01180
DomainATPase_P-typ_cation-transptr_C

ATP2A1 ATP2A2 ATP2A3

9.91e-0617473IPR006068
DomainCation_ATPase_C

ATP2A1 ATP2A2 ATP2A3

9.91e-0617473PF00689
DomainCation_ATPase_N

ATP2A1 ATP2A2 ATP2A3

1.19e-0518473PF00690
DomainCation_ATPase_N

ATP2A1 ATP2A2 ATP2A3

1.19e-0518473SM00831
DomainCUB_dom

ADGRB3 CUBN CSMD1 CSMD2

1.26e-0557474IPR000859
DomainATPase_P-typ_cation-transptr_N

ATP2A1 ATP2A2 ATP2A3

1.41e-0519473IPR004014
DomainHAD-like_dom

ATP10B ATP2A1 ATP2A2 ATP2A3

4.61e-0579474IPR023214
DomainNa/solute_symporter_CS

SLC5A5 SLC5A2

1.72e-048472IPR018212
DomainCUB

CUBN CSMD1 CSMD2

2.54e-0449473PF00431
DomainCUB

CUBN CSMD1 CSMD2

2.69e-0450473SM00042
Domain-

CUBN CSMD1 CSMD2

3.03e-04524732.60.120.290
DomainNA_SOLUT_SYMP_1

SLC5A5 SLC5A2

3.36e-0411472PS00456
DomainNA_SOLUT_SYMP_2

SLC5A5 SLC5A2

4.03e-0412472PS00457
DomainSSF

SLC5A5 SLC5A2

4.03e-0412472PF00474
DomainNa/solute_symporter

SLC5A5 SLC5A2

4.03e-0412472IPR001734
DomainNA_SOLUT_SYMP_3

SLC5A5 SLC5A2

4.03e-0412472PS50283
DomainTSP_1

ADAMTSL1 UNC5B ADGRB3

5.34e-0463473PF00090
DomainTSP1

ADAMTSL1 UNC5B ADGRB3

5.85e-0465473SM00209
DomainTSP1_rpt

ADAMTSL1 UNC5B ADGRB3

5.85e-0465473IPR000884
DomainTSP1

ADAMTSL1 UNC5B ADGRB3

5.85e-0465473PS50092
DomainCupredoxin

PRPF8 PKHD1L1

1.39e-0322472IPR008972
DomainDEATH

UNC5B IRAK3

2.09e-0327472SM00005
DomainDeath

UNC5B IRAK3

3.11e-0333472PF00531
DomainGPS

PKD1 ADGRB3

3.30e-0334472SM00303
DomainGPS

PKD1 ADGRB3

3.50e-0335472PF01825
DomainGPS

PKD1 ADGRB3

3.70e-0336472PS50221
DomainGPS

PKD1 ADGRB3

3.90e-0337472IPR000203
DomainDeath_domain

UNC5B IRAK3

4.11e-0338472IPR000488
DomainDEATH_DOMAIN

UNC5B IRAK3

4.11e-0338472PS50017
PathwayKEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA

ATP2A1 ATP2A2 ATP2A3

8.49e-078363M47955
PathwayREACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS

ATP2A1 ATP2A2 ATP2A3

3.31e-0612363M27326
PathwayREACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS

ATP2A1 ATP2A2 ATP2A3

5.46e-0614363MM15052
PathwayREACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES

ATP10B ATP2A1 ATP2A2 ATP2A3

1.11e-0555364M971
PathwayREACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI

ATP2A1 ATP2A2 ATP2A3

1.22e-0518363M614
PathwayREACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES

ATP10B ATP2A1 ATP2A2 ATP2A3

1.28e-0557364MM15643
PathwayREACTOME_PLATELET_CALCIUM_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

4.29e-0527363MM15053
PathwayREACTOME_PLATELET_CALCIUM_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

4.80e-0528363M924
PathwayREACTOME_ION_CHANNEL_TRANSPORT

SLC17A3 ATP10B ATP2A1 ATP2A2 ATP2A3

7.89e-05176365MM15718
PathwayREACTOME_ION_CHANNEL_TRANSPORT

SLC17A3 ATP10B ATP2A1 ATP2A2 ATP2A3

9.49e-05183365M997
PathwayREACTOME_INTERLEUKIN_18_SIGNALING

IL18BP IL18RAP

1.76e-048362M27878
PathwayREACTOME_THYROXINE_BIOSYNTHESIS

SLC5A5 DUOX1

2.26e-049362MM14833
PathwayREACTOME_INTERLEUKIN_1_FAMILY_SIGNALING

NFKBIA IRAK3 IL18BP IL18RAP

2.62e-04123364MM15125
PathwayREACTOME_THYROXINE_BIOSYNTHESIS

SLC5A5 DUOX1

2.82e-0410362M27120
PathwayREACTOME_ION_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

3.47e-0454363M27460
PathwayREACTOME_ION_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

3.47e-0454363MM15202
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC5A5 SLC17A3 ATP10B CUBN ATP2A1 ATP2A2 ATP2A3 SLC5A2

4.37e-04736368M27287
PathwayREACTOME_INTERLEUKIN_1_FAMILY_SIGNALING

NFKBIA IRAK3 IL18BP IL18RAP

5.85e-04152364M899
PathwayREACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES

SLC5A5 DUOX1

8.42e-0417362MM14829
PathwayWP_ALZHEIMERS_DISEASE

ATP2A1 ATP2A2 ATP2A3

8.75e-0474363MM15962
PathwayREACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES

SLC5A5 DUOX1

9.46e-0418362M27118
PathwayREACTOME_PLATELET_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

9.46e-0476363MM15051
PathwayREACTOME_PLATELET_HOMEOSTASIS

ATP2A1 ATP2A2 ATP2A3

1.35e-0386363M916
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC5A5 SLC17A3 ATP10B ATP2A1 ATP2A2 ATP2A3 SLC5A2

1.46e-03681367MM14985
PathwayWP_THYROXINE_THYROID_HORMONE_PRODUCTION

SLC5A5 DUOX1

1.83e-0325362M39353
PathwayREACTOME_CARDIAC_CONDUCTION

ATP2A1 ATP2A2 ATP2A3

2.27e-03103363MM15196
PathwayWP_TLR4_SIGNALING_AND_TOLERANCE

NFKBIA IRAK3

2.30e-0328362M39561
PathwayBIOCARTA_IL1R_PATHWAY

NFKBIA IRAK3

2.81e-0331362M12095
Pubmed

The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors.

ATP2A1 ATP2A2 ATP2A3

2.80e-09350316410239
Pubmed

Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.

ATP2A1 ATP2A2 ATP2A3

1.12e-08450325110346
Pubmed

The nongastric H+-K+-ATPases: molecular and functional properties.

ATP2A1 ATP2A2 ATP2A3

1.12e-08450310362770
Pubmed

Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.

ATP2A1 ATP2A2 ATP2A3

9.75e-08750324786561
Pubmed

Gene knockout studies of Ca2+-transporting ATPases.

ATP2A1 ATP2A2 ATP2A3

1.56e-07850310951186
Pubmed

Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides.

ATP2A1 ATP2A2 ATP2A3

1.56e-07850327923914
Pubmed

Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.

ATP2A1 ATP2A2 ATP2A3

1.56e-07850319033399
Pubmed

A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.

ATP2A1 ATP2A2 ATP2A3

2.33e-07950325640239
Pubmed

Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.

ATP2A2 ATP2A3

2.03e-06250218295663
Pubmed

Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.

ATP2A2 ATP2A3

2.03e-06250219650915
Pubmed

Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.

ATP2A1 ATP2A2

2.03e-06250212556521
Pubmed

A genetic association study of CSMD1 and CSMD2 with cognitive function.

CSMD1 CSMD2

2.03e-06250227890662
Pubmed

Training induced decrease in oxygen cost of cycling is accompanied by down-regulation of SERCA expression in human vastus lateralis muscle.

ATP2A1 ATP2A2

2.03e-06250218953100
Pubmed

Regulation of SERCA pumps expression in diabetes.

ATP2A2 ATP2A3

2.03e-06250225270119
Pubmed

The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.

CSMD1 CSMD2

2.03e-06250221439553
Pubmed

SERCA overexpression reduces hydroxyl radical injury in murine myocardium.

ATP2A1 ATP2A2

2.03e-06250216798816
Pubmed

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

CSMD1 CSMD2

2.03e-06250224408017
Pubmed

Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.

ATP2A2 ATP2A3

2.03e-06250221885870
Pubmed

Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest.

ATP2A1 ATP2A2

2.03e-06250219644701
Pubmed

Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.

ATP2A2 ATP2A3

2.03e-06250219962989
Pubmed

Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.

ATP2A1 ATP2A2

2.03e-06250214638697
Pubmed

Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology.

ATP2A1 ATP2A2

2.03e-06250210603953
Pubmed

Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.

ATP2A1 ATP2A2

2.03e-06250212975374
Pubmed

Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm.

ATP2A1 ATP2A2

2.03e-06250215718407
Pubmed

Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.

ATP2A1 ATP2A2

2.03e-06250234769190
Pubmed

SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis.

ATP2A1 ATP2A2

2.03e-06250211402072
Pubmed

The ER-Localized Transmembrane Protein EPG-3/VMP1 Regulates SERCA Activity to Control ER-Isolation Membrane Contacts for Autophagosome Formation.

ATP2A1 ATP2A2 ATP2A3

4.22e-062250328890335
Pubmed

Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3.

ATP2A2 ATP2A3

6.07e-06350215161756
Pubmed

Identification of two new members of the CSMD gene family.

CSMD1 CSMD2

6.07e-06350212906867
Pubmed

Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.

ATP2A1 ATP2A2

6.07e-06350215972723
Pubmed

Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.

ATP2A1 ATP2A2

6.07e-06350227055500
Pubmed

Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.

ATP2A1 ATP2A2

6.07e-06350216754798
Pubmed

Sarcoplasmic reticulum Ca2+ ATPase pump is a major regulator of glucose transport in the healthy and diabetic heart.

ATP2A1 ATP2A2

6.07e-06350225615793
Pubmed

Modulation of endoplasmic reticulum calcium pump by Bcl-2.

ATP2A2 ATP2A3

6.07e-0635029788433
Pubmed

Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.

ATP2A2 ATP2A3

6.07e-06350216973504
Pubmed

Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.

ATP2A1 ATP2A2

6.07e-0635029038922
Pubmed

Alteration of RANKL-induced osteoclastogenesis in primary cultured osteoclasts from SERCA2+/- mice.

ATP2A2 ATP2A3

6.07e-06350219419309
Pubmed

Specific effects of endurance and sprint training on protein expression of calsequestrin and SERCA in mouse skeletal muscle.

ATP2A1 ATP2A2

6.07e-06350222466636
Pubmed

Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

ATP2A1 ATP2A2

6.07e-06350211526231
Pubmed

Biology, structure and mechanism of P-type ATPases.

ATP2A1 ATP2A2 ATP2A3

9.95e-062950315071553
Pubmed

Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.

ATP2A1 ATP2A2

1.21e-05450212074580
Pubmed

Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart.

ATP2A1 ATP2A2

1.21e-0545029295312
Pubmed

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease.

IL18BP IL18RAP

1.21e-05450216043644
Pubmed

Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs).

ATP2A1 ATP2A2

1.21e-05450212032137
Pubmed

SERCA1a can functionally substitute for SERCA2a in the heart.

ATP2A1 ATP2A2

1.21e-0545029887021
Pubmed

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

ATP2A1 ATP2A2

1.21e-05450210555147
Pubmed

SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets.

ATP2A2 ATP2A3

1.21e-05450218068335
Pubmed

Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity.

IL18BP IL18RAP

2.02e-05550218092318
Pubmed

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster.

RTEL1 TNFRSF6B

2.02e-05550210655513
Pubmed

TNFα signaling regulates cystic epithelial cell proliferation through Akt/mTOR and ERK/MAPK/Cdk2 mediated Id2 signaling.

NFKBIA PKD1

2.02e-05550226110849
Pubmed

The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy.

ATP2A1 ATP2A2

2.02e-05550230299255
Pubmed

Genome-wide association study of glioma and meta-analysis.

RTEL1 TNFRSF6B

2.02e-05550222886559
Pubmed

Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.

ATP2A1 ATP2A2 ATP2A3

2.28e-053850330786075
Pubmed

Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult.

SLC5A5 DUOX1

3.03e-05650217332529
Pubmed

Early Developmental Disruption of Type 2 Deiodinase Pathway in Mouse Skeletal Muscle Does Not Impair Muscle Function.

ATP2A1 ATP2A2

5.64e-05850227967605
Pubmed

Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.

ATP2A1 ATP2A2

5.64e-05850211784029
Pubmed

Common variants in SLC17A3 gene affect intra-personal variation in serum uric acid levels in longitudinal time series.

SLC16A9 SLC17A3

5.64e-05850220162743
Pubmed

The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm.

ATP2A1 ATP2A2

7.25e-05950215253893
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

TGFB1I1 SETX PKD1 PCDHA5 CSMD2 PRPF8 SLC5A2

8.37e-0573650729676528
Pubmed

CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases.

NFKBIA IRAK3

9.05e-051050218378686
Pubmed

The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis.

ATP2A1 ATP2A2

1.10e-041150212122109
Pubmed

Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.

SLC16A9 SLC17A3

1.10e-041150219890391
Pubmed

O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.

ADAMTSL1 ADGRB3 CUBN

1.76e-047550320637190
Pubmed

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

PKD1 ATP2A1 ATP2A2 ATP2A3

1.80e-0419550417110338
Pubmed

A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.

FBN2 SLA

2.72e-041750222832960
Pubmed

Dynamic regulation of sarcoplasmic reticulum Ca(2+) stores by stromal interaction molecule 1 and sarcolipin during muscle differentiation.

ATP2A1 ATP2A2

2.72e-041750222411552
Pubmed

Non conservation of function for the evolutionarily conserved prdm1 protein in the control of the slow twitch myogenic program in the mouse embryo.

ATP2A1 ATP2A2

3.05e-041850222522309
Pubmed

Overexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotype.

ATP2A1 ATP2A2

3.79e-042050218978355
Pubmed

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.

SLC17A3 CUBN

3.79e-042050223824729
Pubmed

Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.

PKD1 CUBN

4.18e-042150227591083
Pubmed

Maternal exercise intergenerationally drives muscle-based thermogenesis via activation of apelin-AMPK signaling.

ATP2A1 ATP2A2

4.59e-042250235081489
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ADAMTSL1 ADGRB3 TRAK2

4.73e-041055039628581
Pubmed

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.

NFKBIA IRAK3

5.48e-042450220448286
Pubmed

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.

ADGRB3 CSMD1 CSMD2 SLA

5.76e-0426550419240061
Pubmed

Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies.

UNC5B CSMD2

7.48e-042850218839057
Pubmed

Heritable Thoracic Aortic Disease Overview

FBN2 PKD1

8.59e-043050220301299
Pubmed

Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.

ATP2A1 ATP2A2

9.17e-043150216140986
Pubmed

Hnf1b haploinsufficiency differentially affects developmental target genes in a new renal cysts and diabetes mouse model.

PKD1 CUBN

1.24e-033650233737325
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

PKD1 PCDHA5 CSMD2 ATP2A3

1.29e-0332950417474147
Pubmed

Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay.

PKD1 CUBN

1.31e-033750216319116
Cytoband20q13.3

RTEL1 TNFRSF6B

2.18e-042050220q13.3
GeneFamilyATPases Ca2+ transporting

ATP2A1 ATP2A2 ATP2A3

6.57e-0793731209
GeneFamilySolute carriers

SLC5A5 SLC16A9 SLC17A3 SLC25A23 SLC5A2

1.19e-03395375752
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CSMD1 CSMD2

6.06e-03573721179
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ADAMTSL1 FBN2 ADGRB3 IRAK3 CSMD1 CSMD2

8.32e-08195506d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ADAMTSL1 FBN2 ADGRB3 IRAK3 CSMD1 CSMD2

8.32e-0819550619853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 GPR20 ADGRB3 CSMD1 SLA

1.12e-0616450543630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 GPR20 ADGRB3 CSMD1 SLA

1.12e-06164505108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 GPR20 ADGRB3 CSMD1 SLA

1.12e-0616450546208f18325976c89f572f6627aea0582142b92d
ToppCellwk_20-22-Hematologic_Lymphocytic-NK-Activated_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

RTEL1 NFKBIA CST7 SLA IL18RAP

1.68e-061785055b19dbf9dc8e41e6a16a2abbb798d49ee8d8653f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 UNC5B SLA ATP2A3

2.30e-05148504f85dc34f6a4a15ecffa4fbd5644dea12ce30089b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 UNC5B SLA ATP2A3

2.30e-051485044b1fdf90c585f89cee1cf521db4e3fafc9d74d9a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 UNC5B SLA ATP2A3

2.30e-0514850455826b7e9f79ab78a93abd4fc662bc37aa121471
ToppCellfacs-Aorta-Heart-24m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR20 SLC17A3 CST7 SLA

2.56e-051525041da25f913b0fb167f66e539aef509ca44893a878
ToppCell15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class

CST7 SLA IL18RAP PKHD1L1

3.28e-05162504e190c496ed1e206b86566edfee23c99a99fe90d0
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLC5A5 TGFB1I1 GPR20 CSMD1

3.36e-0516350451dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC5A5 UNC5B ADGRB3 SLA

3.44e-05164504f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 CUBN CSMD1 CSMD2

3.69e-051675043edb0570e583bb527165bcd8a4c25a042054043b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

3.78e-05168504fa0d251693935116adf633d02b7ec4a295100865
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

4.05e-05171504f5014e3c387fe3118944af392abe10d6b9b0abab
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 UNC5B ADGRB3 SLA

4.14e-0517250408a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 UNC5B ADGRB3 SLA

4.14e-05172504553701349444eb366df3c11f54bb093434f153c6
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

4.24e-051735048888434641ea554a9b62c436e87920378eef29cd
ToppCell10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue

SLC17A3 NFKBIA CST7 IL18RAP

4.43e-05175504b4e4b66e89f79999768a6192c8404cb2465f920b
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells)

TGFB1I1 FBN2 ADGRB3 CSMD2

4.53e-05176504852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells)

TGFB1I1 FBN2 ADGRB3 CSMD2

4.53e-05176504d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NFKBIA CST7 SLA IL18RAP

4.63e-0517750447813ad05527ea583e736b54b7a48f7ad90c3aef
ToppCellLPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.73e-05178504afcc92e8fe313c85eaf617cf4dbc3058da6c99d6
ToppCellCOVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

4.73e-0517850423a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCellfacs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL18BP ATP2A3 PKHD1L1 FAM135A

4.73e-051785049f59a9af232d77bb55603a7776dbf9749ea652f2
ToppCell21-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class

NFKBIA CST7 SLA IL18RAP

4.73e-05178504d2e1f6b7933b7da2682393e5ff5e03cdd8f64761
ToppCellLPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.73e-05178504bd689205bc92cda5f71df64c2332ff76adcd84b4
ToppCellLPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.84e-05179504d0a03e498afcfeb657037889685ecd77bed07e6c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

4.84e-0517950478fae47ec9bff4e0159a86a281e831d7f8ee925a
ToppCellLPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.84e-05179504d034651a5a355a58f5e15db627869f4feebdfe35
ToppCellCOVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

4.94e-05180504358923e4228035a3e90e2957392089219e90dcd7
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

4.94e-051805041363b3254470f6ff98630d1df83a1bdbacc137e0
ToppCellCOVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

4.94e-05180504864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCellLPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.94e-05180504c0c07937839652e01df10cc1e70aa005800ea6f6
ToppCellLPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

4.94e-05180504079c199425dd3c220f03c6dca1823946f07580a1
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.05e-051815049542c19edc9bd2cba68c01c2a8407705398e3011
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.05e-051815048f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCellCOVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

5.05e-051815046980ea624151da32b7f537f263e40fcb87a02e81
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN CSMD1

5.16e-05182504e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

5.16e-05182504243c783675df495ea4112dbf710712c44ea6b4f1
ToppCellcellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IRAK3 CST7 SLA IL18RAP

5.16e-051825041932d77491d6d46278f01fd70eb469ef1b356619
ToppCellCerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32

TGFB1I1 ADAMTSL1 GPR20 ATP2A3

5.16e-05182504da61e7cb2537c567968d8bd8baf537ecdff0ab18
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN CSMD1

5.16e-0518250457bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCellCerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32

TGFB1I1 ADAMTSL1 GPR20 ATP2A3

5.16e-05182504b2f03f61aebb5920595fed8b9d6799a09353419b
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

5.16e-0518250418790a394dc32b3cef99cdbf826392c520e38b4a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.27e-05183504facd6dbe0851b537d70a899ac7485714ab27d071
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.27e-0518350484b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCelldroplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC5A5 DUOX1 FBN2 ATP10B

5.27e-0518350499ab7a43527eb226027efbcd8c0b6a8e46fc3c93
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN CSMD1

5.27e-0518350485446581999cd66b171c4f69b7eb8b0bbbaa8617
ToppCelldroplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC5A5 DUOX1 FBN2 ATP10B

5.27e-0518350428916f0597690ff534578be2cb715b485cb1de1a
ToppCellCOVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

5.38e-05184504dc71f22583fc54b89b242cbb602f4bbe86f576ec
ToppCellCOVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

5.50e-051855041bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCellLPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NFKBIA IRAK3 SLA IL18RAP

5.50e-051855049b5fd87ea9d05e051ff1251578ecfbe5e8652853
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NFKBIA CST7 SLA IL18RAP

5.50e-051855048314dc608bc837df3037e89afd9db39737374ebc
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.61e-051865048287146f0ba415ea04475588117d4668ae00f75c
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TGFB1I1 GPR20 CSMD1 CSMD2

5.61e-05186504a95744b8649096bd7cfc3591a02841fa411085b3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.73e-0518750471eb26ebf60cb0848e5bf1cd01edccda621aecd8
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.73e-05187504dcf6475ece5b34d9d58a0d1f51c18acedb19c119
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.73e-05187504f1356273bd3587b6883295edf15cb9cdb706c057
ToppCellCOVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type

SLC16A9 SLC17A3 CUBN SLC5A2

5.73e-05187504738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.85e-05188504f3edcefeef2ce19086032d98b243c02a6d542b38
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TGFB1I1 ADAMTSL1 GPR20 APBA1

5.85e-05188504d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCellILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NFKBIA CST7 SLA IL18RAP

5.85e-05188504d26894d1066a70e4b32ae41fff1c4718f2591ba9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.85e-051885040792432cd4c564dea1102241ea9884f7ced7658c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.97e-05189504204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCellcellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IRAK3 CST7 SLA IL18RAP

5.97e-05189504fedab592be1d6520325b8c1b659b0a4dc3f4fe4d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

5.97e-0518950413fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

ADAMTSL1 SLC17A3 IRAK3 PKHD1L1

5.97e-0518950475c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellPCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CST7 SLA IL18RAP ATP2A3

6.10e-05190504bee6a438e217b2abd57aef2a80a9fe14a298d223
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

COL13A1 ADGRB3 IRAK3 PKHD1L1

6.10e-05190504656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NFKBIA IRAK3 CST7 SLA

6.10e-05190504212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TGFB1I1 GPR20 CSMD1 CSMD2

6.10e-0519050473d94fbae92029745989a8712eed8b99fd84c193
ToppCellPCW_10-12-Immune_Lymphocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CST7 SLA IL18RAP ATP2A3

6.10e-051905049b56763d62e1ed50006a5b90b160c5a82aab515b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

6.22e-051915043c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

6.22e-051915041c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

L1TD1 CSKMT CSMD1 ATP2A3

6.22e-0519150454f07e4de61735051498846afb44b1798bed8144
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FBN2 ADGRB3 IRAK3 SLA

6.22e-0519150447a2afc4102199b4bc76bd01b2967c8016186462
ToppCellCOVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type

ADAMTSL1 SLC17A3 IRAK3 PKHD1L1

6.35e-05192504c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 COL13A1 ADGRB3 PKHD1L1

6.35e-0519250425cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN CSMD1

6.35e-051925043e1a4cb0d83efd502c8613d41a1692bdda5860ed
ToppCellRV-10._Endothelium_II|World / Chamber and Cluster_Paper

ADAMTSL1 SLC17A3 IRAK3 PKHD1L1

6.48e-051935042531266bc57339d4e2b22a88817008e32b8c1598
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TGFB1I1 ADAMTSL1 GPR20 ATP2A3

6.61e-05194504bf34737ae2dc218f890fbb9201c308b324415749
ToppCellLV-10._Endothelium_II|LV / Chamber and Cluster_Paper

ADAMTSL1 SLC17A3 IRAK3 PKHD1L1

6.61e-05194504b6cc849fa08599bff9839ef382d190cc964e273e
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TGFB1I1 ADAMTSL1 GPR20 ATP2A3

6.61e-051945044ebed7a6731b88c8359860072cbeba355a7e90ac
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|343B / Donor, Lineage, Cell class and subclass (all cells)

NFKBIA CST7 SLA IL18RAP

6.74e-051955041af6fd96634236d5910fd085ff2d532862303d6b
ToppCell5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NFKBIA CST7 SLA IL18RAP

6.74e-05195504a7c70284ac47dcc6f47ee2805b76b14edfa1c0b9
ToppCellhuman_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

APBA1 IRAK3 SLA LILRB5

6.74e-05195504ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type

ADAMTSL1 COL13A1 ADGRB3 IRAK3

6.88e-05196504ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NFKBIA IRAK3 CST7 SLA

6.88e-051965046230b4a26770d30f1ab83345c087f03be1be0f9e
ToppCellwk_20-22-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NFKBIA CST7 SLA IL18RAP

6.88e-05196504a2f938022a080202bce5bb157d13b86b69054468
ToppCellSevere-NK|Severe / Disease group and Cell class

NFKBIA CST7 SLA IL18RAP

6.88e-0519650466130d38b67e51e2385de8a89227759fd137999c
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

APBA1 IRAK3 SLA LILRB5

6.88e-05196504cbc727b55b6433a701b1a331028a49960fcee6ee
ToppCellbackground-NK_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

CST7 SLA IL18RAP ATP2A3

7.01e-05197504e8e1d3e557fe821efe81012e759e35e4ae33ce86
ToppCellBL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NFKBIA IRAK3 CST7 SLA

7.01e-051975041acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NFKBIA CST7 SLA IL18RAP

7.01e-0519750451340570667914bffec741c72a8d09cc46abb8e8
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

7.01e-051975049b038dac4d4d306aa40ec07d79374c4fe9c604a6
ToppCell356C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

NFKBIA CST7 SLA IL18RAP

7.01e-05197504c7cd7960e8f022b1db49485ff153675827efa35e
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

7.15e-05198504a9d72b17adfddb6ac1857c5f094280e86582693b
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC16A9 SLC17A3 CUBN SLC5A2

7.15e-05198504b933bd66f544822fcf1f2aa2d928c31500e2b3f4
DrugATP-EDC

ATP2A1 ATP2A2 ATP2A3

1.04e-0610483CID000195647
Drug1sqc

ATP2A1 ATP2A2 ATP2A3

1.04e-0610483CID000444279
Drug2,5-dimethylquinone

ATP2A1 ATP2A2 ATP2A3

1.43e-0611483CID000008718
Drug1vyq

ATP2A1 ATP2A2 ATP2A3

1.91e-0612483CID004369390
DrugFCCP

NFKBIA ATP2A1 ATP2A2 ATP2A3 SLC5A2

2.29e-06101485CID000003330
Drugagelasine B

PKD1 ATP2A1 ATP2A2 ATP2A3

2.66e-0646484CID006439899
Drugp-hydroxyhippuric acid

ATP2A1 ATP2A2 ATP2A3

3.15e-0614483CID000151012
DrugAC1L1G0K

NFKBIA ATP2A1 ATP2A2 ATP2A3

3.44e-0649484CID000003473
DrugSulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A

UNC5B APBA1 L1TD1 ATP10B SLA FAM135A

3.63e-061984863218_UP
DrugNSC239129

ATP2A1 ATP2A2 ATP2A3

3.93e-0615483CID000084597
DrugAC1L88YH

ATP2A1 ATP2A2 ATP2A3

5.86e-0617483CID000374551
DrugAC1L380G

ATP2A1 ATP2A2 ATP2A3

8.32e-0619483CID000084698
DrugAC1L25Y6

ATP2A1 ATP2A2 ATP2A3

1.51e-0523483CID000015465
Druglanthanum chloride hydrate

ATP2A1 ATP2A2 ATP2A3

1.51e-0523483CID000165791
Drugmonobromobimane

MCHR2 ATP2A1 ATP2A2 ATP2A3

1.61e-0572484CID000114810
Drugcocaethylene

DUOX1 ATP2A1 ATP2A2 ATP2A3

1.70e-0573484CID000002825
DrugEUK-8

ATP2A1 ATP2A2 ATP2A3

1.96e-0525483CID000171249
Drugcyhexatin

ATP2A1 ATP2A2 ATP2A3

1.96e-0525483CID005364545
Drugdodecyl ether

ATP2A1 ATP2A2 ATP2A3

2.21e-0526483CID000020667
Drugoctaethylene glycol

ATP2A1 ATP2A2 ATP2A3

3.09e-0529483CID000078798
DrugFlurandrenolide [1524-88-5]; Up 200; 9.2uM; HL60; HT_HG-U133A

NFKBIA IRAK3 ATP10B ATP2A1 SLC5A2

3.70e-051794852184_UP
DrugPizotifen malate [5189-11-7]; Up 200; 9.4uM; PC3; HT_HG-U133A

NFKBIA IRAK3 SLA ATP2A1 SLC5A2

4.33e-051854855072_UP
DrugDecamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A

DUOX1 APBA1 ATP10B ATP2A1 LILRB5

5.29e-051934854174_UP
Drugdihydropyridine

SLC5A5 PKD1 ATP2A1 ATP2A2 ATP2A3

5.29e-05193485CID000104822
Drugacetyl phosphate

SLC5A5 ATP2A1 ATP2A2 ATP2A3

5.43e-0598484CID000000186
Drugfluorescamine

ATP2A1 ATP2A2 ATP2A3

5.49e-0535483CID000037927
DrugRA-V

ATP2A1 ATP2A2 ATP2A3

5.49e-0535483CID000476891
DrugNSC3260

TGFB1I1 FBN2 ATP2A1 ATP2A2 ATP2A3

5.56e-05195485CID000220461
DrugVidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A

RTEL1 L1TD1 ATP10B IL18BP SLC5A2

5.70e-051964852706_UP
DrugFenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A

PCDHA5 ATP10B CUBN SLA SLC5A2

5.98e-051984852269_UP
DrugBemegride [64-65-3]; Up 200; 25.8uM; HL60; HT_HG-U133A

DUOX1 GPR20 RTEL1 APBA1 ATP10B

5.98e-051984853051_UP
DrugMyosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A

TGFB1I1 RTEL1 TNFRSF6B PCDHA5 ATP2A3

5.98e-051984854759_DN
DrugCP-320650-01 [172079-28-6]; Up 200; 1uM; MCF7; HT_HG-U133A

COL13A1 APBA1 TNFRSF6B ATP10B SLA

5.98e-051984853908_UP
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A

COL13A1 TNFRSF6B ATP10B ATP2A1 ATP2A2

6.12e-051994853338_UP
DrugPHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A

APBA1 PCDHA5 ATP10B ATP2A3 SLC5A2

6.27e-052004853773_UP
DrugDB06918

RTEL1 TNFRSF6B

6.49e-056482CID009547940
Drugmag-fura-2

ATP2A1 ATP2A2 ATP2A3

6.50e-0537483CID000123839
DrugBE-I

RTEL1 MCHR2 TNFRSF6B

6.50e-0537483CID000445303
Druggramicidin s

ATP2A1 ATP2A2 ATP2A3

6.50e-0537483CID000073357
Drugtrimethyl phosphate

ATP2A1 ATP2A2 ATP2A3

7.62e-0539483CID000010541
Drugcarbidine

ATP2A1 ATP2A2 ATP2A3

8.22e-0540483CID000065684
DrugC12E8

ATP2A1 ATP2A2 ATP2A3

9.53e-0542483CID000123921
Drug1yej

RTEL1 MCHR2 TNFRSF6B

1.17e-0445483CID000449245
Drug5'-pCAA-3'

APBA1 ATP2A1 ATP2A2 ATP2A3

1.44e-04126484CID000482140
DrugR 8231

ATP2A1 ATP2A3

1.55e-049482CID003084926
Drugmagnesium sulfate

ATP2A1 ATP2A2 ATP2A3

1.81e-0452483CID000024083
Drugmagnesium fluoride

ATP2A1 ATP2A2 ATP2A3

1.91e-0453483CID000024546
Drug1,4-dibromobutane

ATP2A1 ATP2A2 ATP2A3

1.91e-0453483CID000008056
Druglanthanum

PKD1 ATP2A1 ATP2A2 ATP2A3

1.93e-04136484CID000023926
Drugtricyclohexyltin chloride

ATP2A1 ATP2A3

1.94e-0410482CID000076539
Druglipoarabinomannan

NFKBIA IRAK3

2.36e-0411482ctd:C050016
Drugpersulfate

ATP2A1 ATP2A3

2.36e-0411482CID000024413
DrugAC1L1JAO

ATP2A1 ATP2A2 ATP2A3

2.38e-0457483CID000004955
DrugAC1NSKPI

ATP2A1 ATP2A2 ATP2A3

2.38e-0457483CID005311482
DrugDantrolene-13C3

PKD1 ATP2A1 ATP2A2 ATP2A3

2.47e-04145484CID000002951
Drugnimodipine

PKD1 ATP2A1 ATP2A2 ATP2A3

2.47e-04145484CID000004497
Drugtoxaphene

ATP2A1 ATP2A2 ATP2A3

2.50e-0458483CID005284469
Drugethylketocyclazocine

ATP2A1 ATP2A2 ATP2A3

2.50e-0458483CID000135018
DrugCC270

ATP2A1 ATP2A2 ATP2A3

2.63e-0459483CID006918852
Drugsanguinarine

ATP2A1 ATP2A2 ATP2A3

2.77e-0460483CID000005154
Drug3,5-dihydroxyphenylglycine

ATP2A1 ATP2A2 ATP2A3

2.77e-0460483CID000108001
Drug6-formylindolo(3,2-b)carbazole

ATP2A1 ATP2A2 ATP2A3

2.77e-0460483ctd:C111855
DrugBay K 8644

PKD1 ATP2A1 ATP2A2 ATP2A3

2.81e-04150484CID000002303
DrugPST-2744

ATP2A1 ATP2A3

2.83e-0412482CID009841834
DrugCresotic Acid

RTEL1 TNFRSF6B

2.83e-0412482CID000006738
DrugI-Q-S

DUOX1 ATP2A1 ATP2A2 ATP2A3

3.26e-04156484CID000003540
Drug9,10-dimethylanthracene

ATP2A1 ATP2A3

3.34e-0413482CID000013076
Drugdisulfiram

RTEL1 TNFRSF6B IRAK3 ATP2A2

3.43e-04158484CID000003117
Drug2-(aminomethyl)pyrrolidine

ATP2A1 ATP2A2 ATP2A3 SLC5A2

3.68e-04161484CID000072032
Drugchlordecone

ATP2A1 ATP2A2 ATP2A3

3.83e-0467483CID000000299
Drugstrontium

ATP2A1 ATP2A2 ATP2A3

4.00e-0468483CID000104798
DrugtBuBHQ

ATP2A1 ATP2A2 ATP2A3

4.18e-0469483CID000002374
DrugL-beta-aspartyl phosphate

ATP2A1 ATP2A2 ATP2A3

4.18e-0469483CID000000832
Drugcaged ATP

ATP2A1 ATP2A2 ATP2A3

4.36e-0470483CID000123806
DrugPyrethroids

ATP2A1 ATP2A2 ATP2A3

4.54e-0471483CID000005053
DiseaseBrody myopathy (implicated_via_orthology)

ATP2A1 ATP2A2 ATP2A3

3.55e-093463DOID:0050692 (implicated_via_orthology)
Diseasecoronary aneurysm

UNC5B CSMD1 CSMD2

2.24e-0535463EFO_1000881
Diseaseheart disease (implicated_via_orthology)

ATP2A1 ATP2A2 ATP2A3

2.88e-0538463DOID:114 (implicated_via_orthology)
Diseasehomocysteine measurement

SLC17A3 CUBN CSMD1

5.14e-0546463EFO_0004578
Diseaseglucose homeostasis measurement, acute insulin response measurement

ATP2A2 ATP2A3

3.58e-0418462EFO_0006831, EFO_0006896
Diseaseanorectal malformation

RTEL1 CSMD2

4.00e-0419462MONDO_0019938
Diseasetemperament and character inventory

FBN2 SLA

6.42e-0424462EFO_0004825
DiseaseTEMPS-A questionnaire

ADGRB3 CSMD1

6.97e-0425462EFO_0004783
Diseasemelanoma (is_implicated_in)

RTEL1 NFKBIA

1.29e-0334462DOID:1909 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
PSPLCIATCGGTLST

CSMD1

1966

Q96PZ7
LGDSTPTCRIISCGE

CSMD2

2646

Q7Z408
TPSVTLIVGSGLSCL

ADGRB3

876

O60242
VTLSVLGVTGSRPCC

GPR20

181

Q99678
TTGISPTVVGCCALV

DNHD1

2131

Q96M86
LPSVETLGCTSVICS

ATP2A1

336

O14983
LPSVETLGCTSVICS

ATP2A3

336

Q93084
PQGTCLTFSLLCTLG

ATP10B

751

O94823
GVTIGTLCCFPLVSL

DUOX1

596

Q9NRD9
TLLAFCCLVLSTTGG

CST7

6

O76096
VGLLASPVCSLCVSS

SLC16A9

61

Q7RTY1
LGSDICLTPAGSSCI

LY6G5C

76

Q5SRR4
LLTLSCGLSTLCQSG

SLC17A3

321

O00476
LLGSTGSISCPSLSC

IL18RAP

166

O95256
LQGSCTSCPSSIITL

NFU1

206

Q9UMS0
VPLNGTLSLSCVACS

IL18BP

76

O95998
LLCVPGCLTVSGPST

CD300H

16

A0A0K2S4Q6
SPCSLTCGVGLQTRD

ADAMTSL1

676

Q8N6G6
LICLGTPCVISGSIS

FAM135A

971

Q9P2D6
SVVLCTLTLNLPTCG

OR2W1

156

Q9Y3N9
PLRVLDVGCGTSSLC

CSKMT

76

A8MUP2
SVLICLGLSVGPRTC

LILRB5

6

O75023
CLASVGVLTQSCTTP

NFKBIA

156

P25963
PCSVICGSISSANIL

IRAK3

286

Q9Y616
CTRGKPTLLCSSAVG

PCDHA5

731

Q9Y5H7
FGGPLCTIITSLDTC

MCHR2

101

Q969V1
CSSTLGSLPLCTCLP

CUBN

366

O60494
LPSVETLGCTSVICS

ATP2A2

336

P16615
LTPVCCSSGITLTLG

FHIP1A

441

Q05DH4
SSLSLIGGTLLCLSC

CLDN14

171

O95500
GTSLVGLPLSTCQSI

APBA1

711

Q02410
SPGSCGLLTLALCSL

COL13A1

41

Q5TAT6
ECSPGSKLSSTGLIC

FBN2

876

P35556
ALLVLCPGTGLSTLC

PKD1

4061

P98161
GLCCVLTTPCLTQST

SLA

166

Q13239
ESPTGTGKTLCLLCT

RTEL1

41

Q9NZ71
ICCTLSTSGGLLLES

SETX

2151

Q7Z333
LSAILPGLSCCSQLT

PRAMEF2

366

O60811
TIIITCSFTPGSCTL

PRPF8

2211

Q6P2Q9
VSGCVTPTESLASLC

TRAK2

521

O60296
CSGLLTLTVSLCTAP

SLC5A2

536

P31639
TLTTVLCGALISCLT

SLC5A5

536

Q92911
CLRGLCGFLSSPTIT

TTC41P

731

Q6P2S7
SSVAGCLATEPLCSL

PKHD1L1

1531

Q86WI1
LSPSVTCGPTGLLLC

UNC5B

601

Q8IZJ1
ILVLLACGTISSTCG

SLC25A23

376

Q9BV35
ATCGLPVTGRCVSAL

TGFB1I1

406

O43294
TCITILCLLAAGSPG

TRBV16

6

A0A087WV62
TLCTSCTGFPLSTRV

TNFRSF6B

191

O95407
PTSQGTGTPCLTLCL

L1TD1

541

Q5T7N2